Analysts Offer Insights on Industrial Goods Companies: EasyJet (OtherEJTTF) and Munters Group AB (OtherMMNNF)
There's a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on EasyJet (EJTTF – Research Report) and Munters Group AB (MMNNF – Research Report) with bullish sentiments.
Confident Investing Starts Here:
EasyJet (EJTTF)
In a report issued on May 21, Marc Zeck from Kepler Capital maintained a Buy rating on EasyJet, with a price target of p680.00. The company's shares closed last Wednesday at $7.13.
Zeck has an average return of 19.1% when recommending EasyJet.
According to TipRanks.com, Zeck is ranked #1439 out of 9559 analysts.
Currently, the analyst consensus on EasyJet is a Moderate Buy with an average price target of $8.79, which is a 23.3% upside from current levels. In a report issued on May 6, J.P. Morgan also maintained a Buy rating on the stock with a £7.30 price target.
Kepler Capital analyst Mats Liss maintained a Buy rating on Munters Group AB on May 21 and set a price target of SEK145.00. The company's shares closed last Monday at $16.05.
Liss has an average return of 24.1% when recommending Munters Group AB.
According to TipRanks.com, Liss is ranked #3362 out of 9559 analysts.
Munters Group AB has an analyst consensus of Moderate Buy, with a price target consensus of $15.94.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
5 hours ago
- Business Insider
Analysts' Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quince Therapeutics (QNCX – Research Report) and Moderna (MRNA – Research Report). Confident Investing Starts Here: Quince Therapeutics (QNCX) In a report issued on June 4, Jason McCarthy from Maxim Group maintained a Buy rating on Quince Therapeutics, with a price target of $6.00. The company's shares closed last Friday at $1.17. According to McCarthy 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -19.2% and a 28.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Brainstorm Cell Therapeutics, and SELLAS Life Sciences Group. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Quince Therapeutics with a $6.67 average price target. Moderna (MRNA) In a report released today, Matt Phipps from William Blair reiterated a Hold rating on Moderna. The company's shares closed last Friday at $27.46. According to Phipps is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.1% and a 41.7% success rate. Phipps covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Ultragenyx Pharmaceutical, and Janux Therapeutics Inc. Currently, the analyst consensus on Moderna is a Hold with an average price target of $49.29, an 88.1% upside from current levels. In a report issued on May 27, Barclays also maintained a Hold rating on the stock with a $40.00 price target.
Business Insider
20 hours ago
- Business Insider
Analysts Offer Insights on Consumer Cyclical Companies: Five Below (FIVE) and Autoliv (ALV)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Five Below (FIVE – Research Report) and Autoliv (ALV – Research Report). Confident Investing Starts Here: Five Below (FIVE) Barclays analyst Seth Sigman maintained a Hold rating on Five Below on June 5 and set a price target of $120.00. The company's shares closed last Friday at $127.35. According to Sigman 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.0% and a 53.9% success rate. Sigman covers the NA sector, focusing on stocks such as Driven Brands Holdings, Floor & Decor Holdings, and Advance Auto Parts. Five Below has an analyst consensus of Moderate Buy, with a price target consensus of $118.63, which is a -7.0% downside from current levels. In a report issued on May 28, Citi also maintained a Hold rating on the stock with a $121.00 price target. Autoliv (ALV) Kepler Capital analyst Alexandre Raverdy maintained a Buy rating on Autoliv on June 5 and set a price target of $100.00. The company's shares closed last Friday at $105.62. According to Raverdy is ranked #5408 out of 9607 analysts. Autoliv has an analyst consensus of Strong Buy, with a price target consensus of $111.31, a 4.8% upside from current levels. In a report issued on May 28, UBS also maintained a Buy rating on the stock with a $123.00 price target.
Business Insider
20 hours ago
- Business Insider
Wizz Air Holdings (WIZZ) Receives a Hold from Kepler Capital
In a report released on June 5, Marc Zeck from Kepler Capital maintained a Hold rating on Wizz Air Holdings (WIZZ – Research Report), with a price target of p1,600.00. The company's shares closed yesterday at p1,174.00. Confident Investing Starts Here: Zeck covers the Industrials sector, focusing on stocks such as Kuehne + Nagel International AG, DHL Group, and DSV A/S. According to TipRanks, Zeck has an average return of 13.3% and a 70.97% success rate on recommended stocks. In addition to Kepler Capital , Wizz Air Holdings also received a Hold from J.P. Morgan's Harry Gowers in a report issued yesterday. However, on June 5, Bernstein maintained a Buy rating on Wizz Air Holdings (LSE: WIZZ). Based on Wizz Air Holdings' latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of p1.81 billion and a net profit of p317.7 million. In comparison, last year the company earned a revenue of p1.82 billion and had a net profit of p344 million Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of WIZZ in relation to earlier this year.
